ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · XTLB

Atlas market file · Equity · Middle East

XTL Biopharmaceuticals Ltd.XTLB

Last close
2.2
Change
+4.76%
96-bar range
0.018 – 2.2
As of
27 Jul 2026

XTL Biopharmaceuticals Ltd. is a healthcare or life-sciences issuer listed as XTLB on TASE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
TASE symbol identity
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot TASE:XTLB

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

2.26551.68721.1090.53077unknown09 Mar20 May27 Jul

â–® up candle   â–® down candle

Latest close2.2
Day change+4.76%
Window high2.2
Window low0.018
96-bar change+9900.00%
SnapshotDaily · 96 bars
As of2026-07-27 06:50 UTC

Weekly outlook: the last 104 weekly closes (+1900.00% over the window).

2.2872unknown11 Aug28 Jul

Source rail: Yahoo Finance chart API (XTLB.TA). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for XTLB. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

XTLB public profile

Company

Healthcare or life-sciences issuer. XTL Biopharmaceuticals Ltd. is connected to current market context, cited company sources and its retained research file.

Market

XTL Biopharmaceuticals Ltd. trades as XTLB on TASE. XTL Biopharmaceuticals Ltd. (XTLB) has a latest verified close of 2.2, up 4.76%, dated 27 Jul 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files XTLB under Healthcare & Medicine Stocks for browsing.

Ticker
XTLB
Exchange
TASE
Sector
Equity Global Directory
Region
Middle East
Asset class
Equity
TradingView

XTLB technical readout

Trend strength (ADX 14)
38.6
Average true range (ATR 14)
0.1151
ATR as % of price
5.23%
Volatility compression (ATR14/ATR50)
1.31x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-27. Indicators are descriptive statistics, not investment advice.

Source authority

XTLB evidence rails

Atlas uses the specific public rails available for XTLB: TASE symbol identity, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 4 rails

Open an Atlas research path on XTLB

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
Atlas Pro

Keep XTLB research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

XTLB FAQ

What is XTL Biopharmaceuticals Ltd. (XTLB)?XTL Biopharmaceuticals Ltd. (XTLB) has a latest verified close of 2.2, up 4.76%, dated 27 Jul 2026. Use this page to check the price chart, company context,...

XTL Biopharmaceuticals Ltd. (XTLB) has a latest verified close of 2.2, up 4.76%, dated 27 Jul 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for XTLB?XTL Biopharmaceuticals Ltd. (XTLB) has a latest verified close of 2.2, up 4.76%, dated 27 Jul 2026. It brings the latest available chart, company context, cited...

XTL Biopharmaceuticals Ltd. (XTLB) has a latest verified close of 2.2, up 4.76%, dated 27 Jul 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files XTLB under Healthcare & Medicine Stocks for browsing.

How often is the XTLB page updated?The XTLB public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The XTLB public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for XTLB?The XTLB file starts with TASE symbol identity and TradingView TASE:XTLB. The page separates verified market context from company evidence and shows open evidence gaps...

The XTLB file starts with TASE symbol identity and TradingView TASE:XTLB. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on XTLB?Yes. The workstation can open a research path for XTLB from the public symbol record and then pull the available public sources for the fuller report.

Yes. The workstation can open a research path for XTLB from the public symbol record and then pull the available public sources for the fuller report.

Is this XTLB page investment advice?No. The XTLB page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The XTLB page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-07-30. Browse FreedomCore Atlas research notes →